RIG
60
2
DE
63
3
NTAP
67
-3
KMI
67
-2
MCHP
41
4
AN
58
4
VRSN
53
-4
BAC
53
3
RHI
59
2
HAS
33
3
KLAC
47
4
WY
54
4
NSC
60
3
CAH
48
-5
WU
32
2
AXP
71
2
CMA
61
5
LB
63
22
AAP
24
6
VTR
47
-7
RIG
60
2
DE
63
3
NTAP
67
-3
KMI
67
-2
MCHP
41
4
AN
58
4
VRSN
53
-4
BAC
53
3
RHI
59
2
HAS
33
3
KLAC
47
4
WY
54
4
NSC
60
3
CAH
48
-5
WU
32
2
AXP
71
2
CMA
61
5
LB
63
22
AAP
24
6
VTR
47
-7
Financhill
Back

Plus Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35

PSTV
Plus Therapeutics

Last Price:
1.20
Seasonality Move:
7.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Plus Therapeutics Price Quote

$1.20
+0.02 (+0%)
(Updated: November 23, 2024 at 5:50 AM ET)

Plus Therapeutics Key Stats

Sell
35
Plus Therapeutics (PSTV) is a Sell
Day range:
$1.12 - $1.23
52-week range:
$1.12 - $2.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.29
P/B ratio:
0%
Volume:
460.4K
Avg. volume:
97.4K
1-year change:
-34.44%
Market cap:
$7M
Revenue:
$0
EPS:
$-2.53

How Much Does Plus Therapeutics Make?

Data Unavailable

Is Plus Therapeutics Growing As A Company?

Data Unavailable

Plus Therapeutics Stock Price Performance

  • Did Plus Therapeutics Stock Go Up Last Month?
    Plus Therapeutics share price went down by -14.66% last month
  • Did PSTV's Share Price Rise Over The Last Year?
    PSTV share price fell by -34.44% over the past 1 year

What Is Plus Therapeutics 52-Week High & Low?

Plus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Plus Therapeutics?

  • How Much Debt Does Plus Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Plus Therapeutics Have?
    Cash and short term investments quarterly total is $4.8M
  • What Is Plus Therapeutics’s Book Value Per Share?
    Book value per share is -0.88

Is Plus Therapeutics Cash Flow Positive?

  • What Is PSTV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$11.2M
  • What Is Plus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.7M
  • What Is Plus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.2M

Plus Therapeutics Return On Invested Capital

Data Unavailable

Plus Therapeutics Earnings Date & Stock Price

Plus Therapeutics Competitors

  • Who Are Plus Therapeutics's Competitors?
    Below is a list of companies who compete with Plus Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Plus Therapeutics Dividend Yield

Plus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 34.22%
Revenue: 0% 28.03%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.00
Upside from Last Price: 1255.93%

Major Shareholders

  • How many PSTV shares are owned by institutional investors?
    717.5K PSTV shares are owned by institutional investors
  • How many PSTV shares are owned by insiders?
    1.2M PSTV shares are owned by insiders